Secondary prophylaxis vs. on-demand treatment to improve quality of life in severe adult haemophilia A patients: A prospective study in a single centre

Vox Sanguinis

Volumn 106, Issue 1, 2014, Pages 68-74

  Aznar, J A ^a   Garcia Dasi M ^a   Perez Alenda S ^a,b   Marco, A ^a   Jaca, M ^a   Moret, A ^a   Querol, F ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Bleeding incidence; Haemophilia A; Musculoskeletal; Quality of life; Secondary prophylaxis

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE;

ABSENTEEISM; ADOLESCENT; ADULT; ANKLE; ARTICLE; BLEEDING; CHILD; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG USE; ELBOW; EMOTIONALITY; HEMARTHROSIS; HEMATOMA; HEMOPHILIA A; HUMAN; JOINT SWELLING; KNEE FUNCTION; MAJOR CLINICAL STUDY; MENTAL HEALTH; MIDDLE AGED; MUSCULOSKELETAL FUNCTION; MUSCULOSKELETAL SYSTEM EXAMINATION; PATIENT SATISFACTION; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SCHOOL CHILD; SECONDARY PREVENTION; SOCIAL BEHAVIOR; YOUNG ADULT;

BLEEDING INCIDENCE; HAEMOPHILIA A; MUSCULOSKELETAL; QUALITY OF LIFE; SECONDARY PROPHYLAXIS;

ADULT; FACTOR VIII; FEMALE; HEMARTHROSIS; HEMOPHILIA A; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES;

EID: 84890807443     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12066     Document Type: Article

References (19)

1. Aledort LM, Haschmeyer RH, Pettersson H: A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994; 236:391-399
2. Manco-Johnson MJ, Abshire TC, Shapiro AD, et al.: Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357:535-544
3. Miners AH, Sabin CA, Tolley KH, et al.: Assessing the effectiveness and cost-effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand's disease. J Intern Med 1998; 244:515-522
4. Aznar JA, Magallon M, Querol F, et al.: The orthopaedic status of severe haemophiliacs in Spain. Haemophilia 2000; 6:170-176
5. Fischer K, van Dijk K, van de Berg H: Late prophylaxis for severe hemophilia: effects of prophylaxis started in adulthood. J Thromb Haemost 2005; 3(Suppl. 1):0R205
6. Collins P, Faradji A, Morfini M, et al.: Efficacy and safety on secondary prophylaxis vs on demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month cross over study. J Thromb Haemost 2010; 8:83-89
7. Valentino L, Mamonov V, Hellmann A, et al.: A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management. J Thromb Haemost 2012; 10:359-367
8. ®: una herramienta útil para la evaluación de la calidad de vida en pacientes adultos con hemofilia. Haematologica (Spanish Ed) 2006; 91(Suppl. 4):13-16
9. Remor E, Arranz P, Quintana M, et al.: Psychometric field study of the new haemophilia quality of life questionnaire for adults: the "A36 Hemofilia-QoL". Haemophilia 2005; 11:603-610
10. Gilbert MS: Prophylaxis: musculoskeletal evaluation. Semin Hematol 1993; 30:3-6
11. Pettersson H, Nilsson IM, Hedner U, et al.: Radiological evaluation of prophylaxis in severe haemophilia. Acta Paediatr Scand 1981; 70:565-570
12. Lundin B, Manco-Johnson ML, Ignas DM, et al.: An MRI scale for assessment of haemophilic arthropathy from the International Prophylaxis Study Group. Haemophilia 2012; 18:962-970
13. Langdell RD, Wagner RH, Brinkhous KM: Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure. J Lab Clin Med 1953; 41:637-647
14. Khawaji M, Astermark J, Berntorp E: Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life. Eur J Haematol 2012; 88:329-335
15. Royal S, Schramm W, Berntorp E, et al.: Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Haemophilia 2002; 8:44-50
16. Noone D, O'Mahony B, van Dijk JP, et al.: A survey of the outcome of prophylaxis, on-demand treatment or combined treatment in 18-35-year old men with severe haemophilia in six countries. Haemophilia 2013; 19:44-50
17. Aznar JA, Marco A, Jiménez-Yuste V, et al.: Is on-demand treatment effective in patients with severe haemophilia? Haemophilia 2012; 18:738-742
18. Petrini P, Seuser A: Haemophilia care in adolescents-compliance and lifestyle issues. Haemophilia 2009; 15(Suppl. 1):15-19
19. Panicker J, Warrier I, Thomas R, et al.: The overall effectiveness of prophylaxis in severe haemophilia. Haemophilia 2003; 9:272-278